NPPA computed the ceiling price for Lamivudine

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on March 06, 2024, issued the Computation of Ceiling Price.

The following has been stated namely: -

• The ceiling price is computed based on the data from October 2023

• The Ceiling Price for the following has been computed namely: -

1. Tenofovir Disproxil Fumarate (A) +Lamivudine (B) +Dolutegravir (C) – Tablet 300 mg (A) + 300 mg (B) + 50 mg (C)

2. DOLUTEGRAVIR + LAMIVUDINE + TENOFOVIR | J5B45

View More Related Updates